Similar articles

• Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.

  Tomeczko J, Pacuszko T, Napora P, Lange A. Tomeczko J, et al. Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S44-7. Bone Marrow Transplant. 1996. PMID: 8899171 Clinical Trial. No abstract available.
• Impact of high-dose chemotherapy with autologous hematopoietic stem cell transplantation on small-cell lung cancer.

  Wang J, Zhan P, Ouyang J, Chen B, Zhou R, Yang Y. Wang J, et al. Lung Cancer. 2009 Jul;65(1):126-7. doi: 10.1016/j.lungcan.2009.03.009. Epub 2009 Apr 24. Lung Cancer. 2009. PMID: 19394108 No abstract available.
• [Dose intensity of chemotherapy in small-cell lung carcinoma].

  Borg C, Ligneau B, Trillet-Lenoir V. Borg C, et al. Bull Cancer. 2001 Sep;88(9):863-70. Bull Cancer. 2001. PMID: 11604359 Review. French.
• [High dosage therapy with stem cell transplantation in neuroendocrine carcinoma].

  Buxhofer V, Ruckser R, Kier P, Habertheuer KH, Zelenka P, Tatzreiter G, Dorner S, Vedovelli H, Sebesta C, Hinterberger W. Buxhofer V, et al. Acta Med Austriaca Suppl. 2000;52:37-9. Acta Med Austriaca Suppl. 2000. PMID: 11261277 German.
• [Which chemotherapy for diffuse forms of small-cell cancers?].

  Pujol JL, Quantin X, Carestia L, Guyot V, Khial F. Pujol JL, et al. Rev Mal Respir. 1999 Jan;16 Suppl 3:S149-55. Rev Mal Respir. 1999. PMID: 10088297 Review. French. No abstract available.